$219.1 1.6%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 1,250 -10.7%
Sentiment 84 0%
Webpage traffic 11,528,000 18.1%
Employee Rating 73 0%
Google Adspend $213,670 29% N/A
Google Trends 83 -7.8%
Linkedin Employees 26,985 N/A
4chan Mentions 0%
Facebook Engagement 162 -8.5%
Facebook followers 12,964 0%
Stocktwits Mentions 1 0%
Stocktwits Subscribers 2,024 0%
Twitter Followers 7,605 0%
Youtube Subscribers 5,610 0%
Instagram Followers 7,498 0.1%
News Mentions 1 0%
Reddit Mentions -100%
Business outlook 65 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About LabCorp

Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries.

Price $219.1
Target Price Sign up
Market Cap $18.2B
Dividend Yield 0.0135
Industry Health Care Services

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '233.06B2.21B851M183M344M
Q2 '233.03B2.19B842M189M340M
Q1 '233.78B2.8B975M213M406M
Q4 '223.67B2.7B970M76M171M
Q3 '222.87B1.98B886M353M542M

Insider Transactions

Wilkinson Peter J filed to sell 2,087 shares at $210.7.
November 20 '23
ANDERSON KERRII B filed to sell 15,275 shares at $211.6.
August 10 '23
Van Der Vaart Sandra D filed to sell 7,605 shares at $240.
July 3 '23
Schroeder Mark S filed to sell 6,687 shares at $216.8.
May 22 '23
Schroeder Mark S filed to sell 6,687 shares at $225.8.
April 3 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.